Innovation Series: AI’s impact on managing ocular surface disease with Peter J. McDonnell, MD, and Laura M. Periman, MD

Peter J. McDonnell, MD, and Laura M. Periman, MD, discuss how artificial intelligence (AI) is transforming ophthalmology, especially in ocular surface disease. Periman highlights the potential of AI to streamline eye health screening and documentation, enabling ophthalmologists to focus on patients who require treatment. They emphasize how AI can enhance clinical efficiency, improve patient outcomes, and assist in making more precise treatment decisions. McDonnell adds that AI will allow ophthalmologists to have a much more productive and satisfying day in the clinic and operating room. Both believe AI will help advance the field and improve patient care globally.